Trey Bowles’ Post

All year we're celebrating phactMI's 10th anniversary with stories from our decade of progress. Today's anecdote about the inspiration for phactMI's collaborative structure comes from one of our founding board members, Stuart Sowder: "I recall when the idea for PhactMI started," says Sowder. "I was at an entrepreneur workshop in Silicon Valley with leaders from across all industries. The workshop was aimed at instilling a new, entrepreneurial mindset in industries that had not seen dramatic leaps forward for decades. One of the main distinctions from our pharma industry and Silicon Valley was their intentional dialogue directly with people who are considered competitors. The spirit that was alive and well in Silicon Valley was an effort to engage the competitive community to help make ideas even better. People honored others in IT, knowing that when it was their turn, their competitors would help enrich their idea with honest feedback and input. When I looked at my 15 year history in pharma, outside of co-promote situations, our industry was not one as seen as forging a collaborative environment across the industry. When I took another step back, I realized that in the medical information space, it was wrong to even consider our ‘competitors’ as such. In Medical Information our only goal was to provide the most accurate and up to date medical and clinical information to HCPs in order for them to make the best possible decisions for how to treat their patients. If the information we provided factually favored our product vs a competitor, so be it…our goal was to make sure the information accurately informed good decision making. As such, there was no competition. This was a major realization that sparked an idea." #medicalinformation #medinfo #druginfo #medaffairs #medicalaffairs

We are celebrating the successful closing of an additional $2.32 Million in Seed Plus funding, closing this round out $500,000 oversubscribed at $5 Million to address underserved #pelvichealth issues. This milestone reflects progress toward our mission to empower women & clinicians with a new gold standard in conservative care for #urinaryincontinence. We extend our deep appreciation to our outstanding partner, Boomerang Ventures for leading this investment round, and we warmly welcome new investors Pier 70 Ventures, Life Science Angels, Orange County Tech Coast Angels MedTech, and Blue Pacific Capital! "Completing this round is an important step in continuing Pelvital's unwavering dedication to provide women with innovative solutions for pelvic health, including the treatment of SUI," says Lydia Zeller, President and CEO of Pelvital. "This funding will play a crucial role in accelerating our commercialization of Flyte with a strong emphasis on expanding payor coverage, enhancing clinical education and clinician awareness, and advocating for upstream screening for UI in primary care and OB/GYN." With this close we are honored to welcome Preetha Ram, PhD, Managing Partner at Pier 70 Ventures, to the Pelvital Board of Directors.   "Joining Pelvital's Board alongside this investment round is truly an honor," she shares. "Pier 70 and I are thrilled to be part of this transformational opportunity, as Pelvital's mission aligns beautifully with our dedication to support disruptive technologies that shake up the status quo in healthcare. Pelvital's pioneering work is shaping a future where women's health receives the attention and innovation it deserves with novel medical devices like Flyte." With two published clinical trials validating Flyte's efficacy, we're excited to offer a groundbreaking treatment option for women. Learn more at Flytetherapy.com. #funding #Innovation #WomenInHealthcare Read the full release here: https://lnkd.in/ggkavYRq

🌟 Weekly Recap: A Week of Collaboration, and Celebration! 🌟 Last week was packed with exciting moments for NLC with HLTH, an exclusive networking dinner, successful ortho/spine panel and a festive venture day. Here's a look back at everything we had done: June 17-20: HLTH Europe We had an incredible time showcasing our health innovations at HLTH Europe. Throughout the week NLC pavilion was filled with inspiring discussions, valuable insights from venture CEOs, and a deep dive into cardiovascular, biotech, ortho/spine and general health tech solutions. It was a fantastic opportunity to connect with industry leaders and explore collaborative opportunities. June 18: Exclusive Networking Dinner We also hosted an exclusive dinner, bringing together decision-makers from the biotech, cardiovascular, ortho-spine, and general health industries. The evening was filled with enriching conversations, networking and great food. June 19: Ortho & Spine Expert Panel Besides growing our community and network, we have also engaged in meaningful discussion with professionals from our Ortho & Spine Expert Panel on technologies currently in our venture creation pipeline. We also invited three of our ventures to share their questions with the experts, as challenges and questions will continue to arise even after the venture is established. June 21: Venture Day  Wrapping up the week, we hosted the annual Venture Day, uniting NLC’s ventures from around the globe. We covered critical topics such as early-stage funding, clinical trials, market access, and more. The event concluded with a graduation ceremony celebrating the achievements of Mitracept , Aerion Bioscience, ChARM, and Neurolieve Biosciences Ltd. Here's to many more fruitful weeks ahead, and cheers to transforming healthcare! 🚀 #HealthcareInnovation #HLTHEurope #VentureDay #Networking #Healthtech #Medtech #Biotech #Cardiovascular #OrthoSpine #PanelDiscussion

For this week's Forbes 30 Under 30 Newsletter, I spoke with the cofounders of Genetesis, a Cincinnati-based biotech company. The biggest takeaway from our conversation? Rely on those around you to grow. The three childhood friends came together in 2013 with a mission to make it easier (and more accurate) to get a diagnosis at the doctors office, with a special focus on cardiology. They're backed by $40 million from investors like Mark Cuban today, but it took years of working with local medical experts, conducting tests with their technology on friends and family, and participating in local pitch competitions and entrepreneurship groups to finalize their proof of concept. Read more about their journey from high-school founders to the Forbes 30 Under 30 list and $40 million in funding here. *Do you know someone else from the Cincinnati area making waves in their industry? We're looking for young founders and leaders for this year's 30 Under 30 Local Cincinnati list. Let us know if you have any nominations by emailing u30lister[at]forbes[dot]com with their name and bio today.* https://lnkd.in/ehH-sbn3 Peeyush Shrivastava, Manny Setegn, Vineet Erasala

Introducing the visionaries behind Axmed: Meet Felix Ohnmacht, Ph.D., the fervent co-founder at the heart of Axmed's mission. But who are the individuals behind this innovative venture, and what motivated them to embark on this journey? "It’s a story of good fortune and freedom, really," Felix says. For him, the decision to start Axmed was rooted in a deep, lifelong appreciation for the ingenuity and resilience of people in Low- and Middle-Income Countries (LMICs). Already in his childhood, Felix explains, he was captivated by communities rich in human-centered values and a knack for experimentation. Inspired by great leaders and mentors in LMICs, he harbored a dream of leveraging his skills to create outsized impact, to meaningfully transform healthcare for those in need through social business. "That company didn't exist, at least not how I imagined it, so we created it," Felix says. When the three co-founders decided to establish Axmed, it wasn't merely about identifying gaps in healthcare delivery; it was about recognizing and supporting the tremendous potential for innovative, sustainable solutions to emerge from within LMICs. It was about transcending short-term interests to increase the accessibility and affordability of medicines, with a strong commercial backbone. "As a technology company, we can push scalability that fundamentally levels the economic playing field and enables real competition on real opportunities," Felix explains. "That's what healthcare needs today, and it has the potential to relieve millions from health challenges so they can enjoy more freedom to thrive." Felix' vision for Axmed is ambitious yet simple: to establish a beacon of change – a new kind of company exemplifying that prioritizing the patient and the public is key to building a thriving business. "Axmed is not just a platform; it's a movement," he declares. "I believe real leadership starts when human beings are in service of others, and the same applies for companies, too. This is where I see Axmed - not just as the world's leading medicines marketplace, but as a trailblazer in ethical business practices and social leadership. In the next weeks, we will introduce Co-Founders Emmanuel Akpakwu and Sofía Radley-Searle - if you have any questions for them about Axmed, simply leave a comment! #Leadership #AccessToMedicine #LeadershipJourney

📣We are thrilled to announce that neuroClues is one of the 10 finalists in the Health Tech Challengers, under the Disruptive Diagnosis track! 🌐 Health Tech Challengers is a prestigious platform for digital health startups, giving them the opportunity to showcase how they are shaping the future of healthcare. Out of 10 finalists in each of the 8 digital health tracks, one winner will be chosen based on their pitch, and we are honored to stand alongside such innovative companies. 💥 How is neuroClues disruptive?  Eye movements are the window into the brain. Long before clinical symptoms appear, eye movements can offer clues about neurological health. By providing an objective, quantifiable, and quick way to measure ocular biomarkers, neuroClues could empower clinicians to make more accurate diagnoses—potentially reducing the need for costly and time-consuming tests. 🎯 In essence, we aim to be the stethoscope for the brain. 🙌 A big thank you to Health Tech Challengers and the panel of experts for this recognition. Congratulations to all the other finalists—we’re excited to hear your pitches and learn how your innovations are transforming healthcare! 🚀 And of course, Antoine Pouppez, we can't wait to see you pitch at Health Tech Forward in December, you've got this! #biomarkers #neuroscience #eyetracking * neuroClues is in research & development phase and its commercial availability is pending regulatory approval.

We're thrilled to announce that SEQUOIA has partnered with the esteemed international network of medical laboratories, INVITRO! This partnership marks a significant milestone for us, akin to our collaboration with the United Nations Population Fund (UNFPA). 🌟 Benefits of Partnership for SEQUOIA 🌟 Teaming up with INVITRO signifies a major leap in our development journey. It's a testament to our dedication to advancing medical projects and underscores the fruitful four years we've invested in our creation. Moreover, this collaboration opens doors to exciting new opportunities for future partnerships with other esteemed organizations. 🌟 Benefits for SEQUOIA Users 🌟 As a token of appreciation for your continued support, we're thrilled to offer our users a fantastic perk: a 10% discount on laboratory tests at all INVITRO branches in the Republic of Belarus! Simply mention the promo code "Sequoia" or show the coupon on your phone screen from the "Checkup" tab in our app to avail of this exclusive discount. We're incredibly proud to join forces with INVITRO in our shared mission to promote better health outcomes for everyone. Curious to learn more about the journey from ideation to implementation and our exciting plans for the future? Dive into our latest blog post here: https://lnkd.in/ddxkGrBM Got any questions or interested in potential partnerships? Drop us a message – we're all ears! #SequoiaHealth #SequoiaPower #SexualHealth #SequoiaCollaboration #Invitro #Partnership #Healthcare #Collaboration #Innovation

🧬 This week's Austin Bio + Health Roundup brings exciting funding announcements, important community events, accolades, partnerships, and milestones from across the Texas Bio Triangle. 🧬 💰 Funding Humanaut Health has secured an $8.7M seed round to bring access to health optimization and longevity to the general population. It's Austin funding Austin, as Midnight Venture Partners joined the round. Don't miss my short interview with Co-founder and CEO Jim Donnelly below! Optmycare, an AI platform in healthcare & risk management, raised a $3 million in Series A funding, led by Austin's own LiveOak Ventures, to accelerate its growth and build out its technology. 🏙️ Community Mark your calendars for the Nucleate Texas Final Pitch Showcase on May 17th. Catch the final pitches from 1pm to 5pm at Highpoint 2222, and discover what's next in platform discoveries, diagnostics, and therapeutics. 🏆 Recognition BrainCheck, a brain health diagnostic and tools company, received the Care Management Innovation Award at the 8th annual MedTech Breakthrough Awards. Congratulations Kim Rodriguez and the entire team for the well-deserved recognition of your work.   🤝 M&A and Partnerships Babson Diagnostics has announced a new partnership with Cynergy Wellness LLC, to provide clinician oversight for Babson’s customer-initiated BetterWay blood tests. One more step in providing access to this novel technology. Congrats David Stein, Eric Olson and the rest of the Babson team. 🚩 Texas Bio Triangle San Antonio-based Hera Biotech has released promising interim results for their groundbreaking endometriosis treatment. The data showed 92% sensitivity, 95% specificity, and 94% overall accuracy compared to histopathology. Congrats Somer Baburek, MBA on this important step in the development of a greatly needed diagnostic. This week underscores breadth and depth of sector. Let's keep the momentum going! What’s Next? #AustinNext #LifeSciences #Healthcare #Biotechnology

Check out this week's Austin Bio + Health Roundup for all the latest news in the ecosystem!

Last week, our very own Jim Donnelly connected with Jason Scharf of Austin Next to discuss the connection between strong health outcomes and a holistic care approach. What you need to know:  - Our model is proactive and preventative  - We provide medical and wellness therapies - We support behavior change with private coaching #humanauthealth, #austinnext, #longevity, #healthspan, #betteraging, #startup, #healthcare